iSAM Funds (UK)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,703
Closed -$295K 279
2026
Q1
$295K Sell
4,703
-1,910
-29% -$153K 0.15% 213
2025
Q4
$631K Sell
6,613
-8,466
-56% -$830K 0.23% 130
2025
Q3
$1.47M Buy
+15,079
New +$1.56M 0.3% 93
2025
Q2
Sell
-12,664
Closed -$1.28M 464
2025
Q1
$1.28M Buy
12,664
+9,171
+263% +$923K 0.63% 39
2024
Q4
$312K Sell
3,493
-18,473
-84% -$1.63M 0.23% 177
2024
Q3
$1.84M Buy
21,966
+12,972
+144% +$1.02M 1.04% 10
2024
Q2
$693K Buy
+8,994
New +$658K 0.52% 67
2024
Q1
Sell
-20,241
Closed -$1.17M 251
2023
Q4
$1.17M Buy
+20,241
New +$1.08M 0.83% 41
2023
Q3
Sell
-32,804
Closed -$1.77M 236
2023
Q2
$1.77M Buy
+32,804
New +$1.71M 1.59% 7
2023
Q1
Sell
-17,053
Closed -$789K 161
2022
Q4
$789K Buy
+17,053
New +$738K 2.36% 6

Other funds holding BSX

iSAM Funds (UK)'s BSX Position: Q2 2026 in Review

iSAM Funds (UK) sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 4,703 shares — an estimated $295K sold.

iSAM Funds (UK) first reported a position in BSX in Q4 2022 and held it in 10 quarters. The position peaked at $1.84M in Q3 2024. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • iSAM Funds (UK) reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • iSAM Funds (UK) sold 4,703 Boston Scientific shares in Q2 2026, an estimated $295K.
  • iSAM Funds (UK) first reported a position in Boston Scientific in Q4 2022 and held it in 10 quarters.
  • iSAM Funds (UK)'s Boston Scientific position peaked at $1.84M in Q3 2024.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on iSAM Funds (UK)'s 13F filing for Q2 2026, filed 12 Aug 2026.